Noninvolvement of CYP2E1 in the (omega-1)-hydroxylation of fatty acids in rat kidney microsomes

被引:12
作者
Amet, Y
Zerilli, A
Goasduff, T
Dreano, Y
Berthou, F
机构
[1] Lab. de Biochimie-Nutrition, EA 948, Faculte de Medecine, 29285-Brest
关键词
CYP2E1; CYP4A; rat kidney; lauric acid; microsomes;
D O I
10.1016/S0006-2952(97)00257-8
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Pyrazole, acetone, and ethanol are known to induce cytochrome P450 2E1 (CYP2E1) and fatty acid (omega-1)-hydroxylation in rat liver microsomes. However, the nature of the P450 enzyme involved in this (omega-1) hydroxylation has not been clearly established in extrahepatic tissues such as kidney. Four enzymatic activities (hydroxylations of chlorzoxazone, dr-nitrophenol, and two fatty acids) were assayed in kidney microsomal preparations of rats treated with CYP2E1 inducers. Per os treatment resulted in large increases (threefold to fivefold) in the chlorzoxazone and 4-nitrophenol hydroxylations, and up to a ninefold increase when ethanol was administered by inhalation. However, neither the omega-hydroxylation nor the (omega-1)-hydroxylation of fatty acids was modified. Immunoinhibition specific to CYP2E1 did not significantly decrease the omega- and (omega-1) lauric acid hydroxylations, while the polyclonal anti-CYP4A1 antibody inhibited in part both the omega- and (omega-1)-hydroxylations. Chemical inhibitions using either CYP2E1 competitive inhibitors (such as chlorzoxazone, DMSO, and ethanol) or P450 mechanism-based inhibitors (such as diethyldithiocarbamate and 17-octadecynoic acid) led to a partial inhibition of the hydroxylations. All these results suggest that fatty acid (omega-1) hydroxylation, a highly specific probe for CYP2E1 in rat and human liver microsomes, is not mediated by CYP2E1 in rat kidney microsomes. In contrast to liver, where two different P450 enzymes are involved in fatty acid omega- and (omega-1)-hydroxylations, the same P450 enzyme, mainly a member of the CYP4A family, was involved in both hydroxylations in rat renal microsomes. (C) 1997 Elsevier Science Inc.
引用
收藏
页码:947 / 952
页数:6
相关论文
共 32 条
[1]   EVIDENCE THAT CYTOCHROME-P450 2E1 IS INVOLVED IN THE (OMEGA-1)-HYDROXYLATION OF LAURIC ACID IN RAT-LIVER MICROSOMES [J].
AMET, Y ;
BERTHOU, F ;
GOASDUFF, T ;
SALAUN, JP ;
LEBRETON, L ;
MENEZ, JF .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1994, 203 (02) :1168-1174
[2]   Cytochrome P450 4A and 2E1 expression in human kidney microsomes [J].
Amet, Y ;
Berthou, F ;
Fournier, G ;
Dreano, Y ;
Bardou, L ;
Cledes, J ;
Menez, JF .
BIOCHEMICAL PHARMACOLOGY, 1997, 53 (06) :765-771
[3]   Validation of the (omega-1)-hydroxylation of lauric acid as an in vitro substrate probe for human liver CYP2E1 [J].
Amet, Y ;
Berthou, F ;
Baird, S ;
Dreano, Y ;
Bail, JP ;
Menez, JF .
BIOCHEMICAL PHARMACOLOGY, 1995, 50 (11) :1775-1782
[4]   Simultaneous radiometric and fluorimetric detection of lauric acid metabolites using high-performance liquid chromatography following esterification with 4-bromomethyl-6,7-dimethoxycoumarin in human and rat liver microsomes [J].
Amet, Y ;
Berthou, F ;
Menez, JF .
JOURNAL OF CHROMATOGRAPHY B-BIOMEDICAL APPLICATIONS, 1996, 681 (02) :233-239
[5]   COMPARISON OF CAFFEINE METABOLISM BY SLICES, MICROSOMES AND HEPATOCYTE CULTURES FROM ADULT HUMAN-LIVER [J].
BERTHOU, F ;
RATANASAVANH, D ;
RICHE, C ;
PICART, D ;
VOIRIN, T ;
GUILLOUZO, A .
XENOBIOTICA, 1989, 19 (04) :401-417
[6]   BOTH CYTOCHROMES P450 2E1 AND 1A1 ARE INVOLVED IN THE METABOLISM OF CHLORZOXAZONE [J].
CARRIERE, V ;
GOASDUFF, T ;
RATANASAVANH, D ;
MOREL, F ;
GAUTIER, JC ;
GUILLOUZO, A ;
BEAUNE, P ;
BERTHOU, F .
CHEMICAL RESEARCH IN TOXICOLOGY, 1993, 6 (06) :852-857
[7]   Baculovirus expression and purification of human and rat cytochrome P450 2E1 [J].
Chen, WQ ;
Peter, RM ;
McArdle, S ;
Thummel, KE ;
Sigle, RO ;
Nelson, SD .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1996, 335 (01) :123-130
[8]   LAURIC ACID AS A MODEL SUBSTRATE FOR THE SIMULTANEOUS DETERMINATION OF CYTOCHROME-P450 2E1 AND 4A IN HEPATIC MICROSOMES [J].
CLARKE, SE ;
BALDWIN, SJ ;
BLOOMER, JC ;
AYRTON, AD ;
SOZIO, RS ;
CHENERY, RJ .
CHEMICAL RESEARCH IN TOXICOLOGY, 1994, 7 (06) :836-842
[9]  
DEMONTELLANO PRO, 1984, J BIOL CHEM, V259, P4136
[10]  
DEMONTELLANO PRO, 1989, PROGR DRUG METABOLIS, V11, P99